Moderna Therapeutics Announces Appointment Of Stephen Hoge, MD As Senior Vice President Of Corporate Development And New Drug Concepts

Moderna Therapeutics Announces Appointment Of Stephen Hoge, MD As Senior Vice President Of Corporate Development And New Drug Concepts

December 19, 2012

CAMBRIDGE, Mass., Dec. 19, 2012 /PRNewswire via COMTEX/ -- Moderna Therapeutics, which is developing a new platform designed to spur the body to create its own therapeutic proteins to treat a wide range of diseases, announced today that Stephen Hoge, MD, currently a partner at McKinsey & Company, will join the company as Senior Vice President of Corporate Development and New Drug Concepts on January 1st, 2013. In this newly created role, Dr.

Blend Therapeutics Appoints Mark Iwicki as Chief Executive Officer

Blend Therapeutics Appoints Mark Iwicki as Chief Executive Officer

December 18, 2012

Pharmaceutical industry leader to drive company growth and strategy with initial focus on new classes of cancer therapies

Blend Therapeutics Closes $16 Million in Series B Financing

Blend Therapeutics Closes $16 Million in Series B Financing

December 18, 2012

Company accelerates product development with two lead programs

BG Medicine Obtains CE Mark for CardioSCORE(TM) Test in Europe

BG Medicine Obtains CE Mark for CardioSCORE(TM) Test in Europe

December 11, 2012

Innovative Blood Test for the Prediction of Major Cardiovascular Events Expected to Launch in the First Half of 2013

Eleven Biotherapeutics Initiates Phase 1b Clinical Study of EBI-005, a Novel, Topically-delivered IL-1 Inhibitor Protein for the Treatment of Dry Eye Disease

Eleven Biotherapeutics Initiates Phase 1b Clinical Study of EBI-005, a Novel, Topically-delivered IL-1 Inhibitor Protein for the Treatment of Dry Eye Disease

December 10, 2012

Follows Successful Completion of Phase 1a Clinical Study

Lead Candidate from Eleven’s AMP-Rx Product Engine for First-of-a-Kind Protein Therapeutics

T2 Biosystems Presents Data on Rapid and Direct Hemostasis Monitoring at ASH 2012

T2 Biosystems Presents Data on Rapid and Direct Hemostasis Monitoring at ASH 2012

December 10, 2012

T2 Biosystems, a company developing direct detection products enabling superior diagnostics, today announced the presentation of data on T2Hemostasis, the first system capable of rapidly characterizing key coagulation, platelet and other hematologic factors directly from whole blood on a single, compact instrument. The data were presented by researchers from the University of Pennsylvania at the 54th Annual Meeting of the American Society for Hematology (ASH) in Atlanta, GA.

Moderna Announces $40 Million In Financing To Advance Development Of New Biotherapeutic Modality: Messenger RNA Therapeutics™

Moderna Announces $40 Million In Financing To Advance Development Of New Biotherapeutic Modality: Messenger RNA Therapeutics™

December 6, 2012
Company announces appointment of Executive Leadership Team and Scientific Advisory Board
 

Governor Patrick Kicks Off Water Industry’s Trade Mission to Israel

Governor Patrick Kicks Off Water Industry’s Trade Mission to Israel

November 28, 2012

Delegation Comprised of Business, Government and Academic Leaders

Selecta Biosciences, Inc.

Selecta Biosciences and Sanofi Sign Global Collaboration to Develop Antigen-Specific Immunotherapies for up to Three Allergy Indications Based on Selecta’s Synthetic Vaccine Particle Technology

Selecta Biosciences and Sanofi Sign Global Collaboration to Develop Antigen-Specific Immunotherapies for up to Three Allergy Indications Based on Selecta’s Synthetic Vaccine Particle Technology

November 28, 2012
  • Collaboration starts with immunotherapy for life-threatening food allergies
  • Novel therapies engineered to produce immune tolerance for two additional antigens to abate allergic immune response in people with severe allergies
TransMedics, Inc.

UCLA performs first 'breathing lung' transplant in United States

UCLA performs first 'breathing lung' transplant in United States

November 26, 2012

Experimental technology could transform field of lung transplantation